BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24356396)

  • 21. Combination of salinomycin and radiation effectively eliminates head and neck squamous cell carcinoma cells in vitro.
    Gehrke T; Hackenberg S; Polat B; Wohlleben G; Hagen R; Kleinsasser N; Scherzad A
    Oncol Rep; 2018 Apr; 39(4):1991-1998. PubMed ID: 29436675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck.
    Teknos TN; Islam M; Arenberg DA; Pan Q; Carskadon SL; Abarbanell AM; Marcus B; Paul S; Vandenberg CD; Carron M; Nor JE; Merajver SD
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):204-11. PubMed ID: 15781759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxytocin inhibits head and neck squamous cell carcinoma cell migration by early growth response-1 upregulation.
    Kim J; Kang SM; Lee HJ; Choi SY; Hong SH
    Anticancer Drugs; 2017 Jul; 28(6):613-622. PubMed ID: 28452807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
    Qiu K; Huang Z; Huang Z; He Z; You S
    Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifactorial Experimental Design to Optimize the Anti-Inflammatory and Proangiogenic Potential of Mesenchymal Stem Cell Spheroids.
    Murphy KC; Whitehead J; Falahee PC; Zhou D; Simon SI; Leach JK
    Stem Cells; 2017 Jun; 35(6):1493-1504. PubMed ID: 28276602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2.
    Tang YL; Jiang J; Liu J; Zheng M; He YW; Chen W; Fan YL; Chen QM; Liao CH; Liang XH
    J Oral Pathol Med; 2015 May; 44(5):337-44. PubMed ID: 25048179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells.
    Yang WH; Lan HY; Tai SK; Yang MH
    Biochem Biophys Res Commun; 2013 Mar; 433(1):24-30. PubMed ID: 23454123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
    Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
    Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
    Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
    Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF-C contributes to head and neck squamous cell carcinoma growth and motility.
    Benke EM; Ji Y; Patel V; Wang H; Miyazaki H; Yeudall WA
    Oral Oncol; 2010 Apr; 46(4):e19-24. PubMed ID: 20227330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
    Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
    Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
    J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of Tiam 1 on cell proliferation and migration in head and neck squamous cell carcinoma cells].
    Xiao P; Fu Q; Li Z; Zhang X; Fu X; Wan R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 29(7):633-7. PubMed ID: 26201191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.